Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Lohan C, Diamantopoulos A, LeReun C, et al. Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation. BMJ Open Gastro 2019;6:e000302. doi: 10.1136/bmjgast-2019-000302
This article was previously published with incorrect information regarding dosing values in the main body, Tables 2 and 9, footnote of Figure 1 and supplementary material.
The correct dosage, considered in the analysis, was 5 mg/kg given as an intravenous infusion induction regimen at 0, 2, and 6 weeks followed by a maintenance regimen of 5 mg/kg IV every 8 weeks thereafter.